122 related articles for article (PubMed ID: 36380366)
41. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.
Jarman EJ; Ward C; Turnbull AK; Martinez-Perez C; Meehan J; Xintaropoulou C; Sims AH; Langdon SP
Breast Cancer Res; 2019 Jan; 21(1):10. PubMed ID: 30670058
[TBL] [Abstract][Full Text] [Related]
42. Advances in targeting epidermal growth factor receptor signaling pathway in mammary cancer.
Kyriakopoulou K; Kefali E; Piperigkou Z; Bassiony H; Karamanos NK
Cell Signal; 2018 Nov; 51():99-109. PubMed ID: 30071291
[TBL] [Abstract][Full Text] [Related]
43. YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition.
Cheng Y; Li W; Liu Y; Cheng HC; Ma J; Qiu L
Chin J Cancer; 2012 May; 31(5):248-56. PubMed ID: 22507221
[TBL] [Abstract][Full Text] [Related]
44. The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.
Whelan KA; Schwab LP; Karakashev SV; Franchetti L; Johannes GJ; Seagroves TN; Reginato MJ
J Biol Chem; 2013 May; 288(22):15865-77. PubMed ID: 23585570
[TBL] [Abstract][Full Text] [Related]
45. Type 1 protein tyrosine kinases in benign and malignant breast lesions.
Suo Z; Emilsen E; Tveit KM; Nesland JM
Histopathology; 1998 Dec; 33(6):514-21. PubMed ID: 9870145
[TBL] [Abstract][Full Text] [Related]
46. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.
Lundgren K; Nordenskjöld B; Landberg G
Br J Cancer; 2009 Nov; 101(10):1769-81. PubMed ID: 19844232
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
[TBL] [Abstract][Full Text] [Related]
48. Aerotaxis in Halobacterium salinarium is methylation-dependent.
Lindbeck JC; Goulbourne EA; Johnson MS; Taylor BL
Microbiology (Reading); 1995 Nov; 141 ( Pt 11)():2945-53. PubMed ID: 8535523
[TBL] [Abstract][Full Text] [Related]
49. Time-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen species.
Calvani M; Comito G; Giannoni E; Chiarugi P
PLoS One; 2012; 7(10):e38388. PubMed ID: 23144690
[TBL] [Abstract][Full Text] [Related]
50. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.
Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J
Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938
[TBL] [Abstract][Full Text] [Related]
51. Repression of hypoxia-inducible factor-1 contributes to increased mitochondrial reactive oxygen species production in diabetes.
Zheng X; Narayanan S; Xu C; Eliasson Angelstig S; Grünler J; Zhao A; Di Toro A; Bernardi L; Mazzone M; Carmeliet P; Del Sole M; Solaini G; Forsberg EA; Zhang A; Brismar K; Schiffer TA; Rajamand Ekberg N; Botusan IR; Palm F; Catrina SB
Elife; 2022 Feb; 11():. PubMed ID: 35164902
[TBL] [Abstract][Full Text] [Related]
52. Hypoxia Selectively Enhances Integrin α
Ju JA; Godet I; Ye IC; Byun J; Jayatilaka H; Lee SJ; Xiang L; Samanta D; Lee MH; Wu PH; Wirtz D; Semenza GL; Gilkes DM
Mol Cancer Res; 2017 Jun; 15(6):723-734. PubMed ID: 28213554
[TBL] [Abstract][Full Text] [Related]
53. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
Li W; Cao L; Chen X; Lei J; Ma Q
Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
[TBL] [Abstract][Full Text] [Related]
54. Oxygen taxis and proton motive force in Azospirillum brasilense.
Zhulin IB; Bespalov VA; Johnson MS; Taylor BL
J Bacteriol; 1996 Sep; 178(17):5199-204. PubMed ID: 8752338
[TBL] [Abstract][Full Text] [Related]
55. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
[TBL] [Abstract][Full Text] [Related]
56. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.
Balanis N; Wendt MK; Schiemann BJ; Wang Z; Schiemann WP; Carlin CR
J Biol Chem; 2013 Jun; 288(25):17954-67. PubMed ID: 23653350
[TBL] [Abstract][Full Text] [Related]
57. Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer.
Bol GM; Raman V; van der Groep P; Vermeulen JF; Patel AH; van der Wall E; van Diest PJ
PLoS One; 2013; 8(5):e63548. PubMed ID: 23696831
[TBL] [Abstract][Full Text] [Related]
58. The NADPH Oxidases DUOX1 and NOX2 Play Distinct Roles in Redox Regulation of Epidermal Growth Factor Receptor Signaling.
Heppner DE; Hristova M; Dustin CM; Danyal K; Habibovic A; van der Vliet A
J Biol Chem; 2016 Oct; 291(44):23282-23293. PubMed ID: 27650496
[TBL] [Abstract][Full Text] [Related]
59. Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells.
Padró M; Louie RJ; Lananna BV; Krieg AJ; Timmerman LA; Chan DA
BMC Cancer; 2017 Mar; 17(1):203. PubMed ID: 28320353
[TBL] [Abstract][Full Text] [Related]
60. TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway.
Jin W; Chen BB; Li JY; Zhu H; Huang M; Gu SM; Wang QQ; Chen JY; Yu S; Wu J; Shao ZM
Mol Cell Biol; 2012 Jan; 32(1):50-63. PubMed ID: 22025675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
